What happened to blood substitutes?

Transfusion Clinique et Biologique

Volumn 12, Issue 5, 2005, Pages 374-379

  Stowell, C P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Blood substitutes; Hemoglobin based oxygen carriers; Oxygen delivery; Transfusion

Indexed keywords

BLOOD SUBSTITUTE; DIASPIRIN CROSSLINKED HEMOGLOBIN; DRUG CARRIER; HEMOGLOBIN; HEMOSPAN; MACROGOL; OXYGEN; OXYGLOBIN; PEG HEMOGLOBIN; POLYMERIZED HEMOGLOBIN; RECOMBINANT HEMOGLOBIN; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; DIFFUSION COEFFICIENT; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG MECHANISM; DRUG STABILITY; EUROPE; HUMAN; KIDNEY DISEASE; LICENSING; NORTH AMERICA; ONCOTIC PRESSURE; PROTEIN MODIFICATION; SAFETY; TOXICITY; VISCOSITY;

ANIMALS; BLOOD SUBSTITUTES; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HEMOGLOBINS; HUMANS; MODELS, ANIMAL; OXYHEMOGLOBINS; STRESS, MECHANICAL;

EID: 29144443581     PISSN: 12467820     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tracli.2005.10.002     Document Type: Article

References (71)

1. C.P. Stowell, J. Levin, B.D. Spiess, and R.M. Winslow Progress in the development of blood substitutes Transfusion 41 2001 287 299
2. C.P. Stowell Hemoglobin based oxygen carriers Curr. Opin. Hematol. 9 2002 537 543
3. J.R. Hess Update on alternative oxygen carriers Vox Sang. 87 Suppl 2 2004 132 135
4. E.L. Bloomfield, and B.J. Leone The safety of hemoglobin blood substitutes Anesth. Analg. 97 2003 323 332
5. R. Chatterjee, E.V. Welty, T.Y. Walder, R.Y. Walder, S.L. Pruitt, and P.H. Rogers Isolation and characterization of a new hemoglobin derivative cross-linked between the α chains (Lysine 99α1-99α2) J. Biol. Chem. 26 1986 9929 9937
6. R. Saxena, A.D. Wijnhoud, H. Carton, W. Hacke, M. Kaste, and R.J. Przybelski Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke Stroke 30 1999 993 996
7. E.P. Sloan, M. Koenigsberg, D. Gens, M. Cipolle, J. Runge, and M.N. Mallory Diaspirin cross-linked hemoglobin (DCHLb) in the treatment of severe traumatic hemorrhagic shock. A randomized controlled efficacy trial JAMA 282 1999 1857 1864
8. M.L. Lamy, E.K. Dailey, J.F. Brichant, R.P. Larbuisson, R.H. Demeyere, and E.A. Vandermeersch Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery Anesthesiol 92 2000 646 656
9. E.P. Sloan, M. Koenigsberg, P.H. Brunett, R.P. Bynoe, J.A. Morris, G. Tinkoff DCLHb Traumatic Hemorrhagic Shock Study Group Post-hoc mortality analysis of the efficacy trial of diaspirin cross-linked hemoglobin in the treatment of severe traumatic hemorrhagic shock J. Trauma 52 2002 887 895
10. J.B. Gibson, R.A. Maxwell, J.B. Schweitzer, T.C. Fabian, and K.G. Proctor Resuscitation from severe hemorrhagic shock after traumatic brain injury using saline, shed blood, or a blood substitute Shock 17 2002 234 244
11. J.G. Adamson, B.J. Bonaventura, S.E. Song, S.F. Langlois, I.D. MacDonald, and C. Moore Production, characterization, and clinical evaluation of Hemolink, an oxidized raffinose cross-linked hemoglobin-based blood substitute A.S. Rudolph R. Rabinovici G.Z. Feuerstein Red blood cell substitutes 1998 Marcel Dekker, Inc. New York 335 351
12. F.J.L. Carmichael, A.C.Y. Ali, J.A. Campbell, S.F. Langlois, G.P. Biro, and A.R. Willan A phase I study of oxidized raffinose cross-linked human hemoglobin Crit. Care Med. 28 2000 2283 2292
13. D.C.H. Cheng Safety and efficacy of o-raffinose cross-linked human hemoglobin (Hemolink) in cardiac surgery Can. J. Anesth. 48 2001 S41 S48
14. A.G. Greenburg, H.W. Kim Hemolink Study Group Use of an oxygen therapeutic as an adjunct to intraoperative autologous donation to reduce transfusion requirements in patients undergoing coronary artery bypass graft surgery J. Am. Coll. Surg. 198 2004 373 383
15. http://www.hemosol.com/presspop.cfm?newsID=2063.
16. J. Sprung, J.D. Kindscher, J.A. Wahr, J.H. Levy, T.G. Monk, and M.W. Moritz The use of bovine hemoglobin glutamer-250 (Hemopure) in surgical patients: results of a multicenter, randomized single-blinded trial Anesth. Analg. 94 2002 799 808
17. G.M. LaMuraglia, P.J. O'Hara, W.H. Baker, T.C. Naslund, E.J. Norris, and J. Li The reduction of allogenic transfusion requirement in aortic surgery with hemoglobin-based solution J. Vasc. Surg. 31 2000 299 308
18. S.M. Kasper, F. Grune, M. Walter, N. Amr, H. Erasmi, and W. Buzello Effects of increased doses of bovine hemoglobin on hemodynamics and oxygen transport in patients undergoing preoperative hemodilution for elective abdominal aortic surgery Anesth. Analg. 87 1998 284 291
19. T. Standl, S. Wilhelm, E.P. Horn, M. Burmeister, M. Gundlach, and J. Schulte am Esch Präoperative Hämodilution mit bovinem Hämoglobin. Akute hämodynamische Auswirkungen bei Patienten in der Leberchirurgie Anaesthesist 46 1997 763 770
20. 2 capacity Surgery 95 1984 433 438
21. S.A. Gould, E.E. Moore, D.B. Hoyt, J.M Burch, J.B. Haenel, and J. Garcia The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery J. Am. Coll. Surg. 187 1998 113 120
22. S.A. Gould, E.E. Moore, F.A. Moore, J.B. Haenel, J.M. Burch, and H. Sehgal Clinical utility of human polymerized hemoglobin as a blood substitute following acute trauma and urgent surgery J. Trauma 43 1997 325 332
23. E.E. Moore, S.A. Gould, D.B. Hoyt, and J.M. Haenel Clinical utility of human polymerized hemoglobin as a blood substitute following trauma and emergent surgery Shock 7 S1 1997 145
24. http://phx.corporate-ir.net/phoenix.zhtml?c=91374RM
25. http://phx.corporate-ir.net/phoenix.zhtml?c=91374. R. M. Winslow Current status of blood substitute research: towards a new paradigm J. Int. Med. 253 2003 508 517
26. 2 delivery by low-p50 hemoglobin: a new basis for hemoglobin-based oxygen carriers Artif. Cells Blood Substit. Immobil. Biotechnol. 33 2005 1 12
27. M. Bjorkholm, B. Fagrell, R. Przybelski, N. Winslow, M. Young, and R.M. Winslow A phase I single blind clinical trial of a new oxygen transport agent (MP4), human hemoglobin modified with maleimide-activated polyethylene glycol Haematologica 90 2005 505 515
28. http://www.sangart.com/press/?pID=1045727680.
29. P.W. Buehler, and A.I. Alayash Toxicity of hemoglobin solutions; in search of in vitro and in vivo model systems Transfusion 44 2004 1516 1530
30. J.R. Hess, V.W. Macdonald, and W.W. Brinkley Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin J. Appl. Physiol. 74 1993 1769 1778
31. P.E. Keipert, A. Gonzales, C.L. Gomez, V.W. MacDonald, J.R. Hess, and R.M. Winslow Acute changes in systemic blood pressure and urine output of conscious rats following exchange transfusion with diaspirin-crosslinked hemoglobin solution Transfusion 33 1993 701 708
32. R.J. Przybelski, E.K. Dailey, and M.L. Birnbaum The pressor effect of hemoglobin - good or bad? R.M. Winslow K.D. Vandegriff M. Intaglietta Advances in blood substitutes: industrial opportunities and medical challenges 1997 Birkhäuser Boston 71 85
33. E. Freilich, D. Freilich, M. Hacker, L. Leach, S. Patel, and J. Hebert The hemodynamic effects of diaspirin cross-linked hemoglobin in dopamine-resistant endotoxic shock in swine Artif Cells Blood Substit Immobil Technol 31 2002 83 98
34. L.A. Vane, J.S. Funston, R. Kirscher, R. Kirschner, D Harper, and D.J. Deyo Comparison of transfusion with DCLHb or pRBCs for treatment of intraoperative anemia in sheep J. Apply Physiol. 92 2002 343 353
35. J. Hess, V. Macdonald, and R. Winslow Dehydration and shock: an animal model of hemorrhage and resuscitation of battlefield injury Artif. Cells Blood Substit. Immobil. Biotechnol. 20 1992 499 502
36. A. Caron, E. Malfatti, O. Aguejouf, B. Faivre-Fiorina, and P. Menu Vasoconstrictive response of rat mesenteric arterioles following infusion of cross-linked, polymerized, and conjugated hemoglobin solutions Artif. Cells Blood Substit. Immobil. Biotechnol. 29 2001 19 30
37. R.F. Eich, T. Li, D.D. Lemmon, D.H. Doherty, S.R. Curry, and J.F. Aitken Mechanism of NO-induced oxidation of myoglobin and hemoglobin Biochemistry 35 1996 6976 6983
38. J.C. Liao, T.W. Hein, M.W. Vaughn, K.T. Huang, and L. Kuo Intravascular flow decreases erythrocyte consumption of nitric oxide Proc. Natl. Acad. Sci. USA 96 1999 8757 8761
39. A.I. Alayash Oxygen therapeutics: can we tame haemoglobin? Nat. Rev. Drug Discov. 3 2004 152 159
40. F. Rioux, G. Drapeau, and F. Marceau Recombinant human hemoglobin (rHb1.1) selectively inhibits vasorelaxation elicited by nitric oxide donors in rabbit isolated aortic rings J. Cardiovasc. Pharmacol. 25 1995 587 594
41. A.J. Ritchie, S. Hartshorn, A.E. Corsbie, B.A. Callingham, R.D. Latimer, and A. Vuylsteke The action of diaspirin cross-linked haemoglobin blood substitutes on human arterial bypass conduits Eur. J. Cardiothroac. Surg. 18 2000 241 245
42. S.A. Gould, and G.S. Moss Clinical development of human polymerized hemoglobin as a blood substitute World J. Surg. 20 1996 1200 1207
43. Z. Abassi, S. Kotob, F. Pieruzzi, M. Abouassali, H.R. Keiser, and J.C. Fratantoni Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats J. Lab. Clin. Med. 129 1997 603 610
44. M. Doyle, I. Apostol, and B. Kerwin Glutaralderhyde modification of recombinant human hemoglobin alters its hemodynamic properties J. Biol. Chem. 274 1999 2583 2591
45. R.J. Rohlfs, E. Bruner, A. Chiu, A. Gonzales, M.L. Gonzales, and D. Magde Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide J. Biol. Chem. 273 1998 12128 12134
46. C.M. Fitzpatrick, S.A. Savage, J.D. Kerby, W.D. Clouse, and V.S. Kashyap Resuscitation with a blood substitute causes vasoconstriction without nitric oxide scavenging in a model of arterial hemorrhage J. Am. Coll. Surg. 199 2004 693 701
47. R.M. Winslow, A. Gonzales, M. Gonzales, M. Magde, M. McCarthy, and R.J. Rohlfs Vascular resistance and the efficacy of red cell substitutes in a rat hemorrhage model J. Appl. Physiol. 85 1998 993 1003
48. N. Karmakar, and P. Dhar Effect of steady shear stress on fluid filtration through the rabbit arterial wall in the presence of macromolecules Clin. Exp. Pharmacol. Physiol. 23 1996 299 304
49. C. De Wit, C. Schafer, P. Von Bismarck, S.S. Bolz, and U. Pohl Elevation of plasma viscosity induces cell sustained NO-mediated dilation in the hamster cremaster microcirculation in vivo Pflugers - Arch. Eur. J. Physiol. 434 1997 354 361
50. M. Intaglietta, P.C. Johnson, and R.M. Winslow Microvascular and tissue oxygen distribution Cardiovasc. Res. 32 1996 632 643
51. A. Tsai, B. Friesenecker, R.M. Winslow, and M. Intaglietta Functional capillary density changes during blood substitution with αα-Hb and dextran 70: influence on oxygen delivery Art Cells Blood Subs Immob Biotech 22 1994 841 847
52. M. Intaglietta Whitaker lecture 1996. Microcirculation, biomedical engineering and artificial blood Ann. Biomed. Eng. 25 1997 593 603
53. G. Rochon, A. Caron, M. Toussaint-Hacquard, A.I. Alayash, M. Gentils, and P. Labrude Infusion of stroma free hemoglobin at physiologically maintained viscosity delays the onset of vasoconstriction in acute normovolemic hemodilution Hypertension 43 2004 1110 1115
54. 2 Am. J. Physiol. Heart Circ. Physiol. 285 2003 H1600 H1608
55. P. Cabrales, A.G. Tsai, and M. Intaglietta Hyperosmotic-hyperoncotic versus hyperosmotic-hyperviscous: small volume resuscitation in hemorrhagic shock Shock 22 2004 431 437
56. P. Cabrales, M. Intaglietta, and A.G. Tsai Increase plasma viscosity sustains microcirculation after resuscitation from hemorrhagic shock and continuous bleeding Shock 23 2005 549 555
57. K.D. Vandegriff, M. McCarthy, R.J. Rohlfs, and R.M. Winslow Colloid osmotic properties of modified hemoglobins: chemically cross-linked versus polyethylene glycol surface conjugated Biophys. Chem. 69 1997 23 30
58. S. Fischer, M. Burnet, D. Traber, D.S. Prough, and G.C. Kramer Plasma volume expansion with solutions of hemoglobin, albumin and Ringers lactate in sheep Am. J. Physiol. 45 1999 H2194 H2203
59. R. Migita, A. Gonzales, M.L. Gonzales, K.D. Vandegriff, and R.M. Winslow Blood volume and cardiac index in rats after exchange transfusion with hemoglobin-based oxygen carriers J. Appl. Physiol. 82 1997 1995 2002
60. A. Guyton Textbook of medical physiology 1961 W.B. Saunders Philadelphia, PA
61. B.R. Duling, and R.M. Berne Longitudinal gradients in perivascular oxygen tension. A possible mechanism for the participation of oxygen in local regulation of blood flow Circ. Res. 27 1970 669 678
62. H. Kerger, I.P. TorresFilho, M. Rivas, R. Winslow, and M. Intaglietta Systemic and subcutaneous microvascular oxygen tension in conscious Syrian golden hamsters Am. J. Physiol. 268 Heart Circ. Physiol. 37 1994 H802 H810
63. 2 therapeutics Am. J. Physiol. Heart Circ. Physiol. 285 2003 H1411 H1419
64. R. Wettstein, A.G. Tsai, R.M. Winslow, and M. Intaglietta Resuscitation with polyethylene glycol-modified human hemoglobin improves microcirculatory blood flow and tissue oxygenation after hemorrhagic shock in awake hamsters Crit. Care Med. 31 2003 1824 1830
65. 2 carriers on microvascular pressure Am. J. Physiol. Heart Circ. Physiol. 288 2005 H2146 H2153
66. P. Scholander Oxygen transport through hemoglobin solutions Science 131 1960 585 590
67. 2 transport J. Appl. Physiol. 62 1987 791 797
68. T.C. Page, W.R. Light, C.B. McKay, and J.D. Hellums Oxygen transport by erythrocyte/hemoglobin solution mixtures in an in vitro capillary as a model of hemoglobin-based oxygen carrier performance Microvasc. Res. 55 1998 54 64
69. M.R. McCarthy, K.D. Vandegriff, and R.M. Winslow The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers Biophys. Chem. 92 2001 103 117
70. S.N. Vaslef, B.J. Kaminski, and T.L. Talarico Oxygen transport dynamics of acellular hemoglobin solutions in an isovolemic hemodilution model in swine J. Trauma 51 2002 1153 1160
71. 2 carriers determine constriction of resistance arteries and hypertension Am. J. Physiol. Heart Circ. Physiol. 279 2000 H908 H915